Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Lerner

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|September 2, 2006
Preclinical assessment of curcumin as a potential therapy for B-CLLPeter C Everett, John A Meyers, Anthony Makkinje, et al.
Archives of Dermatology|September 19, 2007
Infliximab as a therapy for idiopathic hypereosinophilic syndromeJosephine A Taverna, Adam Lerner, Lynne Goldberg, et al.
Leukemia & Lymphoma|May 29, 2020
Treatment disparities in minority groups with multiple myeloma at a safety-net hospitalMichael Dennis, Asaf Maoz, Diana Cirstea, et al.
Cellular Signalling|January 26, 2011
BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130CasPierre Vanden Borre, Richard I Near, Anthony Makkinje, et al.
Cellular Signalling|January 29, 2002
PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMPRichard Lee, Sharon Wolda, Eunyi Moon, et al.
Journal of Cardiothoracic and Vascular Anesthesia|May 28, 2008
Intraoperative assessment of perivalvular mitral regurgitation: utility of three-dimensional echocardiographySwaminathan Karthik, Sugantha Sundar, Adam Lerner, et al.
Journal of Cellular Physiology|April 12, 2007
AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphologyRichard I Near, Yujun Zhang, Anthony Makkinje, et al.
The Journal of Biological Chemistry|June 20, 2012
Breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas)Anthony Makkinje, Pierre Vanden Borre, Richard I Near, et al.
Journal of Cutaneous Pathology|April 24, 2012
Primary cutaneous CD56 positive lymphoma: a diagnostic conundrum in an unusual case of lymphomaStefan M Schieke, Mohammed A Sharaf, Adam Lerner, et al.
Archives of Dermatology|August 17, 2011
Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatmentAdam Lerner, Angela Beckford, Steve Ugent, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|September 2, 2006
Preclinical assessment of curcumin as a potential therapy for B-CLLPeter C Everett, John A Meyers, Anthony Makkinje, et al.
Archives of Dermatology|September 19, 2007
Infliximab as a therapy for idiopathic hypereosinophilic syndromeJosephine A Taverna, Adam Lerner, Lynne Goldberg, et al.
Leukemia & Lymphoma|May 29, 2020
Treatment disparities in minority groups with multiple myeloma at a safety-net hospitalMichael Dennis, Asaf Maoz, Diana Cirstea, et al.
Cellular Signalling|January 26, 2011
BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130CasPierre Vanden Borre, Richard I Near, Anthony Makkinje, et al.
Cellular Signalling|January 29, 2002
PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMPRichard Lee, Sharon Wolda, Eunyi Moon, et al.
Journal of Cardiothoracic and Vascular Anesthesia|May 28, 2008
Intraoperative assessment of perivalvular mitral regurgitation: utility of three-dimensional echocardiographySwaminathan Karthik, Sugantha Sundar, Adam Lerner, et al.
Journal of Cellular Physiology|April 12, 2007
AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphologyRichard I Near, Yujun Zhang, Anthony Makkinje, et al.
The Journal of Biological Chemistry|June 20, 2012
Breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas)Anthony Makkinje, Pierre Vanden Borre, Richard I Near, et al.
Journal of Cutaneous Pathology|April 24, 2012
Primary cutaneous CD56 positive lymphoma: a diagnostic conundrum in an unusual case of lymphomaStefan M Schieke, Mohammed A Sharaf, Adam Lerner, et al.
Archives of Dermatology|August 17, 2011
Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatmentAdam Lerner, Angela Beckford, Steve Ugent, et al.
Pageof 7